Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results

    Financial Results - Page 6

    Pfizer Q2 net profit falls 14% to Rs 95.8 crore

    Pfizer Q2 net profit falls 14% to Rs 95.8 crore

    Medical Dialogues Bureau18 Nov 2018 9:00 AM IST
    New Delhi: Drug firm Pfizer has recently reported a 13.81 per cent dip in standalone net profit to Rs 95.8 crore for the quarter ended September...
    Bayer CropScience Q2 net profit down 25.13 percent

    Bayer CropScience Q2 net profit down 25.13 percent

    Medical Dialogues Bureau17 Nov 2018 10:15 AM IST
    New Delhi: Agro-chemical firm Bayer CropScience has recently posted 25.13 per cent drop in its net profit at Rs 142.7 crore in the second quarter of...
    AstraZeneca Pharma India Q2 net profit dips 67% to Rs 9.13 Crore

    AstraZeneca Pharma India Q2 net profit dips 67% to Rs 9.13 Crore

    Medical Dialogues Bureau16 Nov 2018 10:30 AM IST
    New Delhi: Drug firm AstraZeneca Pharma India has recently reported a 66.65 per cent dip in its net profit to Rs 9.13 crore for the quarter ended...
    Aurobindo Pharma shares fall 3% after Q2 earnings

    Aurobindo Pharma shares fall 3% after Q2 earnings

    Medical Dialogues Bureau15 Nov 2018 9:45 AM IST
    New Delhi: Shares of Aurobindo Pharma has recently fallen almost 3 per cent after the company reported 21.70 per cent dip in consolidated net profit...
    Wockhardt Q2 net loss widens to Rs 23 Crore

    Wockhardt Q2 net loss widens to Rs 23 Crore

    Medical Dialogues Bureau12 Nov 2018 11:05 AM IST
    India business stood at Rs 455 crore in the quarter as against Rs 452 crore in the same period last year. It contributed 40 per cent of the global...
    Cipla Q2 consolidated net profit declines by 15.64 percent

    Cipla Q2 consolidated net profit declines by 15.64 percent

    Medical Dialogues Bureau7 Nov 2018 9:45 AM IST
    Mumbai: Pharma major, Cipla Ltd has posted a decline of 15. 64 per cent in its consolidated net profit for the quarter ended September 30, 2018, at Rs...
    Torrent Pharma Q2 net profit dips 12 percent to Rs 179 crore

    Torrent Pharma Q2 net profit dips 12 percent to Rs 179 crore

    Medical Dialogues Bureau5 Nov 2018 9:15 AM IST
    New Delhi: Drug firm Torrent Pharmaceuticals has reported a 12.25 per cent dip in its consolidated net profit to Rs 179 crore for the quarter ended...
    Lupin Q2 net profit drops 41.5 Percent to Rs 266 Crore

    Lupin Q2 net profit drops 41.5 Percent to Rs 266 Crore

    Medical Dialogues Bureau3 Nov 2018 10:11 AM IST
    New Delhi: Drug maker Lupin has recently reported a 41.5 per cent decline in its consolidated net profit at Rs 266 crore for the second quarter ended...
    Monsanto India Q2 profit at Rs 24 cr, revenue up 33% at Rs 133.49 cr

    Monsanto India Q2 profit at Rs 24 cr, revenue up 33% at Rs 133.49 cr

    Medical Dialogues Bureau31 Oct 2018 5:14 PM IST
    New Delhi: Seed firm Monsanto India Monday reported a net profit of Rs 24.09 crore for the quarter ended September 2018. Its net loss stood at Rs 6.39...
    Big Pharma Companies to Return to Double-Digit Growth this Fiscal: Crisil

    Big Pharma Companies to Return to Double-Digit Growth this Fiscal: Crisil

    Medical Dialogues Bureau29 Oct 2018 9:45 AM IST
    Domestic revenues of big pharma companies are expected to grow 12-13 per cent this fiscal, given better access to healthcare and deeper penetration of...
    Alembic Pharma Q2 profit up 64 percent to Rs 200 crore

    Alembic Pharma Q2 profit up 64 percent to Rs 200 crore

    Medical Dialogues Bureau27 Oct 2018 10:10 AM IST
    New Delhi: Alembic Pharmaceutical has reported 64.58 per cent rise in consolidated net profit to Rs 200.07 crore for the quarter ended September 30,...
    Jubilant Life Q2 profit up 67 Percent to Rs 210 Crore

    Jubilant Life Q2 profit up 67 Percent to Rs 210 Crore

    Medical Dialogues Bureau24 Oct 2018 9:32 AM IST
    New Delhi: Jubilant Life Sciences has recently reported 67.18 per cent rise in consolidated net profit to Rs 209.77 crore for the quarter ended...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    GSK , Vir Biotechnology enter collaboration to find coronavirus solutions

    GSK , Vir Biotechnology enter collaboration to find coronavirus solutions

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok